ISRCTN03831044已完成不适用
HIV-Infected Patients with Advanced Disease in treatment with HAART use Complementary Alternative Medicine for Reconstitution of CD4 count and for Improving their Health Related Quality of Life over Time
Hospital San Juan de Dios (Chile)0 个研究点目标入组 15 人开始时间: 2010年7月8日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Any adult patient infected with HIV who has a naïve CD4 count < 200 cell/mL and who, despite > 48 weeks of HAART, keep CD4 < 250 cell/mL
- •2. Adherent to HAART and to the controls with the physician in charge of treatment of the HIV-condition
- •3. Patients who modify their HAART regimens are not excluded if plasma HIV-1 RNA levels, remain < 80 copies/m
排除标准
- •Patients who use hydroxyurea, IL-2, IFN-a, or the combination of tenofovir and didanosine, which are known to affect CD4 count increases
研究者
相似试验
已完成
不适用
Impact of HIV and its treatment on reverse cholesterol transportHIVInfection - Acquired immune deficiency syndrome (AIDS / HIV)Cardiovascular - Diseases of the vasculature and circulation including the lymphatic systemAtherosclerosisACTRN12605000494639ational Health and Medical Research Council of Australia (grants # 317811 and 317810(DS)49
已完成
不适用
EUROLOGICAL SYMPTOMS IN HIV POSITIVE PATIENTS ON ANTI-HIV TREATMENTCTRI/2018/01/011514Shri BM Patil Medical College50
Unknown
不适用
Identification and Quantification of HIV CNS Latency BiomarkersHIVHIV-associated Neurocognitive Disorder (HAND)NCT02989285St Vincent's Hospital, Sydney70
已完成
2 期
Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+HIV SeropositivityNCT01174914The Ojai Foundation171
招募中
不适用
Optimal Management of HIV-Infected Adults at Risk for Kidney Complications in Nigeria (R3 Study)Kidney DiseasePACTR201711002808414Vanderbilt University Medical Center280